New first-line treatment for patients with metastatic pancreatic cancer
Approved by the Food and Drug Administration on February 13, 2024. NALIRIFOX, a combination chemotherapy for first-line treatment of metastatic pancreatic adenocarcinoma. Dr. Patrick BolandI am a medical oncologist. Gastrointestinal Oncology Program We conduct research at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New Jersey’s leading cancer program and the only National Cancer […]
BMS Demonstrates Rationale for Opdivo and Yervoy Combination Therapy in First-Line Colorectal Cancer
Photo: California BMS Building Exterior/iStock, hapa bapa Bristol-Myers Squibb on Thursday announced data from the Phase 3 CheckMate-8HW study demonstrating first-line potential for Opdivo (nivolumab) and Yervoy (ipilimumab) combination therapy in metastatic colorectal cancer. . BMS did not provide specific data in Thursday’s announcement, but the company said the combination therapy showed “statistically significant results” […]